KIORA PHARMACEUTICALS, INC. (KPRX) Free cash flow 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.1MFY2025 · since FY2016: -$8.4M → -$10.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.1M | -217.8% |
| FY2024 | $8.6M | +189.5% |
| FY2023 | -$9.6M | +8.4% |
| FY2022 | -$10.4M | +2.9% |
| FY2021 | -$10.7M | -46.4% |
| FY2020 | -$7.3M | +10.0% |
| FY2019 | -$8.2M | +24.9% |
| FY2018 | -$10.9M | -67.0% |
| FY2017 | -$6.5M | +22.7% |
| FY2016 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice